- Home
- FLNC vs OCS Comparison
FLNC vs OCS Comparison
Compare FLNC & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLNC | OCS |
|---|---|---|
| Founded | 2018 | 2003 |
| Country | United States | Switzerland |
| Employees | N/A | 60 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | FLNC | OCS |
|---|---|---|
| Price | $16.98 | $14.11 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 17 | 6 |
| Target Price | $15.71 | ★ $42.00 |
| AVG Volume (30 Days) | ★ 10.5M | 723.4K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,262,830,000.00 | N/A |
| Revenue This Year | $51.23 | $466.06 |
| Revenue Next Year | $21.30 | $479.73 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.60 | $10.52 |
| 52 Week High | $33.51 | $34.48 |
Technical Indicators
Market Signals| Indicator | FLNC | OCS |
|---|---|---|
| Relative Strength Index (RSI) | 37.96 | 43.80 |
| Support Level | $13.05 | $10.52 |
| Resistance Level | $18.21 | $21.82 |
| Average True Range (ATR) | 2.19 | 0.68 |
| MACD | -0.85 | 0.91 |
| Stochastic Oscillator | 5.36 | 92.91 |
Price Performance
Historical ComparisonAbout FLNC Fluence Energy Inc.
Fluence Energy Inc provides intelligent energy storage and optimization software for renewables and storage. Its energy storage solutions and operational services support a more resilient grid and help unlock the potential of renewable portfolios. The company's offerings include energy storage solutions, recurring operational and maintenance services, and Software-as-a-Service (SaaS) products designed to meet customer business needs, performance requirements, in-house capabilities, and risk profiles. Its service plans offer varying levels of training, maintenance, guarantees, warranties, and support for active system management. The company operates in the Americas, APAC and EMEA, with the majority of revenue coming from the Americas.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.